AXL and rheumatoid arthritis: Our ex-vivo patient data further corroborate that Axl and MerTK constitute a dynamic axis in RA, influenced by the synovial tissue inflammatory features, the disease stage, the exposure and the response to targeted treatments and the blockade of critical inflammatory pathways over time.